PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Metabolic Explorer SA (METEX.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0004177046
SectorBasic Materials
IndustryChemicals

Highlights

Market Cap€7.27M
EPS-€0.82
Revenue (TTM)€168.16M
Gross Profit (TTM)€17.90M
EBITDA (TTM)-€40.56M
Year Range€0.11 - €1.22
Target Price€0.20

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Metabolic Explorer SA

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Metabolic Explorer SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%December2024FebruaryMarchAprilMay
-98.60%
352.47%
METEX.PA (Metabolic Explorer SA)
Benchmark (^GSPC)

S&P 500

Returns By Period

Metabolic Explorer SA had a return of -68.71% year-to-date (YTD) and -88.65% in the last 12 months. Over the past 10 years, Metabolic Explorer SA had an annualized return of -26.15%, while the S&P 500 had an annualized return of 10.67%, indicating that Metabolic Explorer SA did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-68.71%9.49%
1 month-34.02%1.20%
6 months-77.09%18.29%
1 year-88.65%26.44%
5 years (annualized)-39.82%12.64%
10 years (annualized)-26.15%10.67%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-3.99%-8.05%-58.42%15.87%
202318.00%-27.29%-9.56%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of METEX.PA is 10, indicating that it is in the bottom 10% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of METEX.PA is 1010
METEX.PA (Metabolic Explorer SA)
The Sharpe Ratio Rank of METEX.PA is 2020Sharpe Ratio Rank
The Sortino Ratio Rank of METEX.PA is 1111Sortino Ratio Rank
The Omega Ratio Rank of METEX.PA is 1010Omega Ratio Rank
The Calmar Ratio Rank of METEX.PA is 33Calmar Ratio Rank
The Martin Ratio Rank of METEX.PA is 55Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Metabolic Explorer SA (METEX.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


METEX.PA
Sharpe ratio
The chart of Sharpe ratio for METEX.PA, currently valued at -0.53, compared to the broader market-2.00-1.000.001.002.003.00-0.53
Sortino ratio
The chart of Sortino ratio for METEX.PA, currently valued at -1.05, compared to the broader market-4.00-2.000.002.004.006.00-1.05
Omega ratio
The chart of Omega ratio for METEX.PA, currently valued at 0.85, compared to the broader market0.501.001.502.000.85
Calmar ratio
The chart of Calmar ratio for METEX.PA, currently valued at -0.89, compared to the broader market0.002.004.006.00-0.89
Martin ratio
The chart of Martin ratio for METEX.PA, currently valued at -1.49, compared to the broader market-10.000.0010.0020.0030.00-1.49
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.27, compared to the broader market-2.00-1.000.001.002.003.002.27
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.22, compared to the broader market-4.00-2.000.002.004.006.003.22
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.39, compared to the broader market0.501.001.502.001.39
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.83, compared to the broader market0.002.004.006.001.83
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.69, compared to the broader market-10.000.0010.0020.0030.008.69

Sharpe Ratio

The current Metabolic Explorer SA Sharpe ratio is -0.53. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Metabolic Explorer SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.53
2.59
METEX.PA (Metabolic Explorer SA)
Benchmark (^GSPC)

Dividends

Dividend History


Metabolic Explorer SA doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-98.95%
-0.68%
METEX.PA (Metabolic Explorer SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Metabolic Explorer SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Metabolic Explorer SA was 98.96%, occurring on May 3, 2024. The portfolio has not yet recovered.

The current Metabolic Explorer SA drawdown is 98.95%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.96%May 22, 20074339May 3, 2024
-10.19%Apr 17, 20073Apr 19, 20078May 2, 200711
-1.54%May 3, 20073May 7, 20072May 9, 20075
-1.43%May 10, 20072May 11, 20071May 14, 20073
-0.98%May 15, 20071May 15, 20073May 18, 20074

Volatility

Volatility Chart

The current Metabolic Explorer SA volatility is 23.95%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%December2024FebruaryMarchAprilMay
23.95%
3.50%
METEX.PA (Metabolic Explorer SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Metabolic Explorer SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items